Transcription factor decoy for AP-1 reduces mesangial cell proliferation and extracellular matrix production in vitro and in vivo.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001483:Base Sequence; D002455:Cell Division / Q000187:drug effects; D003928:Diabetic Nephropathies / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D005109:Extracellular Matrix / Q000378:metabolism* / Q000473:pathology; D015870:Gene Expression; D015316:Genetic Therapy / Q000379:methods*; D005920:Glomerular Mesangium / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology; D008297:Male; D008969:Molecular Sequence Data; D009838:Oligodeoxyribonucleotides / Q000235:genetics*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018808:Transcription Factor AP-1 / Q000235:genetics* / Q000378:metabolism; D014162:Transfection / Q000379:methods
D009838:Oligodeoxyribonucleotides; D018808:Transcription Factor AP-1; D000804:Angiotensin II; D005947:Glucose